42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Clinical trial NCT01381094 · COMPLETED
Trial details
- NCT number
- NCT01381094
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-15
- Primary completion
- 2012-02-16
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.